Your browser doesn't support javascript.
loading
New Approach Methodologies (NAMs) for ad hoc human health risk assessment of food and non-food products - Proceedings of a workshop.
de Wit, Lianne; Hendriks, Hester; van Engelen, Jacqueline; Heusinkveld, Harm; Kienhuis, Anne; Rorije, Emiel; Woutersen, Marjolijn; van der Zee, Margriet; Jeurissen, Suzanne.
Afiliação
  • de Wit L; RIVM, Centre for Prevention, Lifestyle and Health, Bilthoven, the Netherlands.
  • Hendriks H; RIVM, Centre for Safety of Substances and Products, Bilthoven, the Netherlands. Electronic address: hester.hendriks@rivm.nl.
  • van Engelen J; RIVM, Centre for Safety of Substances and Products, Bilthoven, the Netherlands.
  • Heusinkveld H; RIVM, Centre for Health Protection, Bilthoven, the Netherlands.
  • Kienhuis A; RIVM, Centre for Health Protection, Bilthoven, the Netherlands.
  • Rorije E; RIVM, Centre for Safety of Substances and Products, Bilthoven, the Netherlands.
  • Woutersen M; RIVM, Centre for Safety of Substances and Products, Bilthoven, the Netherlands.
  • van der Zee M; Science Lines, Vleuten, the Netherlands.
  • Jeurissen S; RIVM, Centre for Prevention, Lifestyle and Health, Bilthoven, the Netherlands.
Regul Toxicol Pharmacol ; 149: 105615, 2024 May.
Article em En | MEDLINE | ID: mdl-38555098
ABSTRACT
RIVM convened a workshop on the use of New Approach Methodologies (NAMs) for the ad hoc human health risk assessment of food and non-food products. Central to the workshop were two case studies of marketed products with a potential health concern the botanical Tabernanthe iboga which is used to facilitate mental or spiritual insight or to (illegally) treat drug addiction and is associated with cardiotoxicity, and dermal creams containing female sex hormones, intended for use by perimenopausal women to reduce menopause symptoms without medical supervision. The workshop participants recognized that data from NAM approaches added valuable information for the ad hoc risk assessment of these products, although the available approaches were inadequate to derive health-based guidance values. Recommendations were provided on how to further enhance and implement NAM approaches in regulatory risk assessment, specifying both scientific and technical aspects as well as stakeholder engagement aspects.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Produtos para o Consumidor Limite: Humans Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Produtos para o Consumidor Limite: Humans Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda